Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
JPM26: Sanofi looks ahead to lingering US policy hurdles
Though many challenges from the Trump admin have been addressed, Sanofi still has to settle scrutiny of its vaccines and an unexpected FDA rejection.
Darren Incorvaia
Jan 14, 2026 2:28pm
FDA rejects Sanofi MS drug, Corcept Cushing's syndrome therapy
Jan 2, 2026 7:10am
Aldeyra dry eye disease decision hit by FDA delay
Dec 16, 2025 11:55am
Fierce Biotech's Rotten Tomatoes of 2025
Dec 16, 2025 4:30am
ASH 2025 marked by ‘enduring activism’ and ‘cautious optimism’
Dec 9, 2025 3:15pm
Yet another CDER leadership shake-up—Chutes & Ladders
Dec 5, 2025 8:30am
